000 01193 a2200373 4500
005 20250512044601.0
264 0 _c19870626
008 198706s 0 0 eng d
022 _a0378-584X
024 7 _a10.1159/000216368
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKern, P
245 0 0 _aInterferon alpha in the treatment of AIDS-associated Kaposi's sarcoma.
_h[electronic resource]
260 _bOnkologie
_cFeb 1987
300 _a50-2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcquired Immunodeficiency Syndrome
_xtherapy
650 0 4 _aAdult
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
_xadverse effects
650 0 4 _aSarcoma, Kaposi
_xtherapy
650 0 4 _aSkin Neoplasms
_xtherapy
700 1 _aMeigel, W
700 1 _aRácz, P
700 1 _aGottesleben, A
700 1 _aDettke, T
700 1 _aDietrich, M
773 0 _tOnkologie
_gvol. 10
_gno. 1
_gp. 50-2
856 4 0 _uhttps://doi.org/10.1159/000216368
_zAvailable from publisher's website
999 _c3301382
_d3301382